M. Kathleen Behrens - 06 Mar 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for M. Kathleen Behrens
Issuer symbol: SRPT
Transactions as of: 06 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Mar 2023, 19:00:53 UTC
Previous filing: 04 Jan 2023
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Award	$0	+1,523	+0.96%	$0.000000	159,993	06 Mar 2023	Direct	F1
holding	SRPT	Common Stock						10,000	06 Mar 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Award	$0	+3,257		$0.000000	3,257	06 Mar 2023	Common Stock	3,257	$155.99	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024.